Altos Venture
VC Fund
Allschwil, Switzerland
Altos Venture is a venture capital firm that specializes in seed/start-up investments. Founded in 2011, the company is headquartered in Allschwil, Switzerland.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Altos Venture invests in
Stages Altos Venture invests in
Countries Altos Venture invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Walter Fischli
|
|||
Investment Focus
Industry
- Medical 1 (33%)
- E-Commerce 1 (33%)
- Health Care 1 (33%)
- Marketplace 1 (33%)
- Biotechnology 1 (33%)
Stage
- Series B 1 (33%)
- Series D 1 (33%)
- Funding Round 1 (33%)
Country
- South Korea 1 (33%)
- Switzerland 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Walter Fischli
President
|
President | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
IDUS
|
IDUS is an online store that sells watches, home fabric, shoes, rings, earrings, necklaces, bracelets, phone cases, digital accessories, and home interior products. They enable customers to transact directly with sellers over the Internet via a web browser or a mobile app. Their goods benefit customers. | $25.1M / Series D / Jun 08, 2020 | |
ProteoMediX
|
ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer and the personalized treatment thereof.The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinicalstandard.This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient. | $6.1M / Aug 27, 2018 | |
|
ProteoMediX
|
ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer and the personalized treatment thereof.The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinicalstandard.This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient. | $3.7M / Series B / Apr 09, 2014 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Altos Venture invest in?
Altos Venture invests primarily in Medical, E-Commerce and Health Care startups, most often at Series B and Series D stage. Most of the 3 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Altos Venture?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Altos Venture?
The team at Altos Venture includes Walter Fischli (President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
